Gene: PFKFB1
Official Full Name: 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1provided by HGNC
Gene Summary: This gene encodes a member of the family of bifunctional 6-phosphofructo-2-kinase:fructose-2,6-biphosphatase enzymes. The enzyme forms a homodimer that catalyzes both the synthesis and degradation of fructose-2,6-biphosphate using independent catalytic domains. Fructose-2,6-biphosphate is an activator of the glycolysis pathway and an inhibitor of the gluconeogenesis pathway. Consequently, regulating fructose-2,6-biphosphate levels through the activity of this enzyme is thought to regulate glucose homeostasis. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07469 | PFKFB1 Knockout cell line (HEK293) | Human | PFKFB1 | 1:3~1:6 | Negative | Online Inquiry |
PFKFB1 Gene Knockout Cell Lines are engineered cellular models that contain a targeted genetic deletion of the PFKFB1 gene, which encodes a key regulatory enzyme involved in glucose metabolism and cellular energy balance. By eliminating this gene, these cell lines serve as invaluable tools for studying the role of PFKFB1 in metabolic pathways, cellular signaling, and disease states, including cancer and metabolic disorders.
The primary function of these cell lines lies in their ability to mimic the pathological conditions arising from impaired glucose homeostasis. The knockout of PFKFB1 disrupts the production of fructose 2,6-bisphosphate, a potent allosteric activator of phosphofructokinase-1 (PFK-1), leading to altered glycolytic flux and energy production. Researchers can utilize these models to elucidate the metabolic consequences of PFKFB1 loss and to explore potential therapeutic targets for conditions associated with dysregulated glucose metabolism.
The scientific significance of PFKFB1 Gene Knockout Cell Lines extends into both research and clinical applications. In research settings, these cell lines can be harnessed for high-throughput screening assays, investigations into metabolic reprogramming in cancer cells, and studying stress responses in hypoxic environments. Clinically, insights gained from these models may contribute to the development of strategies to treat metabolic syndromes or validate therapeutic agents targeting the PFKFB1 pathway.
These cell lines stand out due to their specificity and the precision with which the PFKFB1 gene is knocked out, allowing for a highly controlled experimental environment. Unlike alternative models that may still express residual PFKFB1 activity, our gene knockout cell lines provide clear and unambiguous disruptions in metabolic pathways, enhancing the clarity of experimental outcomes.
For researchers and clinicians seeking to deepen their understanding of glucose metabolism and its implications in disease, PFKFB1 Gene Knockout Cell Lines offer an unparalleled opportunity for innovation and discovery. Our company specializes in the production of high-quality, genetically modified cell lines designed to empower scientific advancement. With a steadfast commitment to excellence in biological products, we ensure that our offerings facilitate groundbreaking research in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.